Small Molecules, Nanobodies
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
1,584
NCT03492398
A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 29, 2018
Completion: May 28, 2019
NCT04255979
A Study of HY209 in Healthy Male Volunteers for Sepsis
Start: Dec 5, 2019
Completion: Jun 12, 2020
NCT04530643
A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)
Phase: Phase 2
Start: Aug 26, 2020
Completion: Sep 7, 2021
NCT04565379
Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients
Start: Sep 24, 2020
Completion: Apr 13, 2021
NCT05352347
Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients
Phase: Phase 2/3
Start: Apr 12, 2022
Completion: Dec 31, 2024
NCT06024499
Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
Start: Mar 1, 2024
Completion: Mar 31, 2026
Loading map...